rs16857866

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001349206.2(LPIN1):​c.289-780C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 152,164 control chromosomes in the GnomAD database, including 4,905 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.15 ( 4905 hom., cov: 33)

Consequence

LPIN1
NM_001349206.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.88

Publications

3 publications found
Variant links:
Genes affected
LPIN1 (HGNC:13345): (lipin 1) This gene encodes a magnesium-ion-dependent phosphatidic acid phosphohydrolase enzyme that catalyzes the penultimate step in triglyceride synthesis including the dephosphorylation of phosphatidic acid to yield diacylglycerol. Expression of this gene is required for adipocyte differentiation and it also functions as a nuclear transcriptional coactivator with some peroxisome proliferator-activated receptors to modulate expression of other genes involved in lipid metabolism. Mutations in this gene are associated with metabolic syndrome, type 2 diabetes, acute recurrent rhabdomyolysis, and autosomal recessive acute recurrent myoglobinuria (ARARM). This gene is also a candidate for several human lipodystrophy syndromes. [provided by RefSeq, Mar 2017]
LPIN1 Gene-Disease associations (from GenCC):
  • myoglobinuria, acute recurrent, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • hereditary recurrent myoglobinuria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.475 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001349206.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
NM_001349206.2
MANE Select
c.289-780C>T
intron
N/ANP_001336135.1
LPIN1
NM_001261428.3
c.436-780C>T
intron
N/ANP_001248357.1
LPIN1
NM_001349207.2
c.379-780C>T
intron
N/ANP_001336136.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
ENST00000674199.1
MANE Select
c.289-780C>T
intron
N/AENSP00000501331.1
LPIN1
ENST00000256720.6
TSL:1
c.289-780C>T
intron
N/AENSP00000256720.2
LPIN1
ENST00000396098.5
TSL:1
c.307-780C>T
intron
N/AENSP00000379405.1

Frequencies

GnomAD3 genomes
AF:
0.149
AC:
22621
AN:
152046
Hom.:
4880
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.480
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.0686
Gnomad ASJ
AF:
0.00923
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.0195
Gnomad FIN
AF:
0.0122
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0178
Gnomad OTH
AF:
0.107
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.149
AC:
22698
AN:
152164
Hom.:
4905
Cov.:
33
AF XY:
0.144
AC XY:
10735
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.481
AC:
19907
AN:
41424
American (AMR)
AF:
0.0685
AC:
1047
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00923
AC:
32
AN:
3466
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5194
South Asian (SAS)
AF:
0.0193
AC:
93
AN:
4826
European-Finnish (FIN)
AF:
0.0122
AC:
130
AN:
10624
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0178
AC:
1211
AN:
68020
Other (OTH)
AF:
0.106
AC:
224
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
649
1299
1948
2598
3247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0844
Hom.:
1010
Bravo
AF:
0.171
Asia WGS
AF:
0.0640
AC:
222
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.17
DANN
Benign
0.81
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16857866; hg19: chr2-11910718; API